Halia Therapeuticsto Participate in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1x1 Forum

Summary

Halia Therapeutics announced participation in the 6th Annual Needham Private Biotech & MedTech Company Virtual 1x1 Forum. The company is a clinical-stage biopharmaceutical developer of first-in-class therapies targeting inflammasome-driven disease biology.